May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk?

Giulio Francolini¹, Lucia Pia Ciccone¹, Vanessa Di Cataldo¹+7

• ¹Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences "M. Serio," University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences "M. Serio," University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences "M. Serio," University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences "M. Serio," University of Florence, Florence, Italy.